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DOI: 10.1039/b900501nA new immunoassay with biotinylated single-walled carbon
nanotubes as persistent, non-photobleaching Raman biomarkers
demonstrated excellent sensitivity and specificity.Organic fluorophores have been widely used to tag antibodies in
typical immunological assays including an immuno-fluorescent
staining. However, photobleaching of the chromophore limits the life
time and long-term stability, resulting in the disability of researchers
to investigate specimens repeatedly and over long periods.1,2 Nano-
scale particles such as quantum dots1,3 and carbon nanotubes1,4 have
been investigated to overcome this hurdle. Quantum dots are
approximately 100 times more resistant to photobleaching than
organic fluorophores. However, they exhibit a limited life time in
aqueous solutions (approximately 7–12 days)5 and their signal
decreases under prolonged excitation.1 Single-walled carbon nano-
tubes (SWNTs) show persistent, non-photobleaching Raman scat-
tering with some of the highest known cross-sections for single
molecules1,4,6 enabling the detection of the signal from a single carbon
nanotube.7 Single-stranded DNA (ssDNA)-bound SWNT probes
have been employed to tag stem cells1 and to detect particular
sequences of DNA with excellent sensitivity and selectivity.4
Here we present an immunological assay in which antibodies are
non-covalently labeled with SWNTs via biotinylated ssDNA. The
high affinity of the biotin-avidin complex, which is known as one of
the strongest non-covalent bindings between protein and its ligand,
was utilized to combine antimouse IgG with SWNTs. The target
antigen is human cytomegalovirus (HCMV)-encoding protein UL44
which is confined in HCMV-infected human fetal lung fibroblast
(HFLF). HCMV is one of the common agents of congenital infec-
tions and is known to cause fatal opportunistic infection in immuno-
compromised patients such as AIDS.8–10 The first part of the paper is
a confirmation of tethering a SWNT-ssDNA-biotin probe to
a primary antibody (SCMVM34), which is specific to the target
antigen (HCMV-UL44), and the second part describes probing theaSchool of Mechanical Engineering, Sungkyunkwan University, Suwon,
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1294 | Analyst, 2009, 134, 1294–1296amount of the antigen in cell extracts by obtaining the characteristic
Raman band of the nanotube probe complex.
Fig. 1 shows a schematic of the assay mechanism. The sequence of
oligonucleotide is 50-d(GT)15-3
0, and the 30-end is pre-modified with
biotin. The SWNT-ssDNA-biotin probes were prepared utilizing
a similar protocol developed by Zheng et al.11 (see ESI for experi-
mental details†). Previous investigations revealed that the ssDNA
with d(GT)n, n ¼ 10–45, effectively wraps and disperses SWNTs via
p-stacking.11,12 The SWNT-ssDNA-biotin probe was stable for
several months without showing any aggregation. Non-covalent
binding between biotin-(GT)15 and SWNTs provides individual
isolation of nanotubes and conserves their intrinsic electronic/optical
nature. It is expected that multiple biomolecules wrap a nanotube
since the length of the tube is significantly longer than that of biotin-
conjugated ssDNA.
SCMVM34 is a monoclonal antibody and used as a primary
antibody. Dot blotting was carried out to prove specific binding
between the probe complex (SWNT-ssDNA-biotin) and a primary
antibody (SCMVM34). Six 100-fold diluted samples of SCMVM34
were dotted onto a nylon membrane, which has porous structures
with a binding capacity of 100 mg/cm2. Fig. 2 shows a schematic of
SCMVM34 dotted on the nylon membrane (2 ml each spot). A blank
spot with 2 ml of PBS was also prepared as a control. Phosphate
buffered saline (PBS) was loaded instead of SCMVM34. The nylon
membrane was treated in skim milk (2 wt%) for 1 hour after dotting
to prevent non-specific binding of other molecules. In the next step,
biotin-conjugated antimouse IgG (secondary antibody), avidin and
SWNT-ssDNA-biotin were incubated with a molar ratio of 2 : 1 : 2
for 1 hour at room temperature. The incubation was carried out
under mild shaking conditions. Avidin acts as a coupler and has four
identical biotin binding subunits. In a statistical point of view, both
biotin-conjugated antimouse IgG and biotin-ssDNA-SWNT are
expected to bind equally to the biotin acceptor sites of avidin. Finally,
the membrane was washed three times for 15 min each with PBS-TFig. 1 A step-by-step conjugation procedure of the SWNT probe
complex via biotin-avidin interaction. A target antigen is UL44 in
HCMV-infected HFLF. A primary antibody is SCMVM34 and
a secondary antibody is antimouse IgG.
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Fig. 2 A schematic of SCMVM34 prehybridized on the nylon
membrane. Six 100-fold diluted samples of SCMVM34 were dotted on































































View Onlinesolution. The washing process was carried out in a shaker at room
temperature.
Fig. 3a shows Raman spectra from the nylon membrane after dot
blotting (Kaiser Optical RXN1, 785 nm excitation). The tangential
mode (or G peak) of nanotubes at a Raman shift of 1593 cm1,
caused by stretching along C–C bonds of graphene,13 is used to
benchmark specific binding of the nanotube probe. The G peak
intensity increased as the concentration of SCMVM34 increased
from 0.2 ng/mL to 20 mg/mL. The signal was negligible at 2 pg/mL,
and the blank spot did not show any signal. The area under the G
peak was integrated from 1585 to 1615 cm1, and the results are
shown in Fig. 3b. The detection limit of SCMVM34 was 0.2 ng/mL,
which is 106 times better than that of the conventional color reaction
technique as shown in Fig. 3c. The color reaction was performed
using a similar protocol published by Hwang et al.10 Biotin-conju-
gated antimouse IgG and avidin-conjugated peroxidase were serially
reacted and followed by the treatment of substrate with dia-
minobenzidine and hydrogen peroxide. The reaction time was
selected so that the background color change was minimal while the
specific color change was apparent. The characteristic Raman band
did not diminish under a prolonged exposure on the excitation laser
as previously reported1,4 (ESI†). The complex formation between
SWNT-ssDNA-biotin and SCMVM34 was also carried out in
multi-steps. Biotin-conjugated antimouse IgG was first reacted with
SCMVM34 on the nylon membrane. Avidin was reacted in the next
step, and SWNT-ssDNA-biotin was reacted in the last step. This
cross-checking experiment provided an almost identical trend
(ESI†).
The interaction between biotin-tethered SWNTs and SCMVM34
(1 mM) was further verified by fluorescence modulation in aqueousFig. 3 Monitoring of a reaction between a primary antibody
(SCMVM34) and the probe complex (SWNT-ssDNA-biotin-avidin-
biotin-conjugated antimouse IgG): (a) Raman G mode profiles of
nanotubes bound to SCMVM34 on the nylon membrane; (b) integrated
area intensity under the G mode; (c) color reaction. The detection limit
was 0.2mg/mL.
This journal is ª The Royal Society of Chemistry 2009solution. The pre-conjugated SWNT-ssDNA-biotin-avidin-biotin-
conjugated antimouse IgG complex showed strong fluorescence in
the region of infrared, indicating individual suspension of nanotubes
as shown in Fig. 4.14 There was a slight decrease in the fluorescence
intensity after the interaction. The agents such as DNA backbones
and amino acid building blocks of protein cause ion binding to
SWNTs which can lead to a decrease in fluorescence. Biomolecules
adsorbed onto the sidewall of SWNTs also change surface coverage
and modulate the dielectric environment. This results in a shift in the
emission energy from the bandgap of nanotubes by a solvatochromic
mechanism.15–17 The inset in Fig. 4 shows a blue shift (0.7 meV) for
the (6,4) tube upon the binding event carried out in a quartz cuvette
for 4 hours at room temperature. The maximum intensity, before and
after the reaction, was normalized in the inset. The blue shift was also
observed for (7,5) and (6,5) at the excitation wavelength of 785 nm.
The binding of SCMVM34 to the secondary antibody occurred
distant from nanotube surface due to a linker layer in-between, such
as avidin (5 nm) and secondary antibody (8 nm). The blue shift in
fluorescence suggested that the long-range interaction (approximately
by 13 nm) between large biomolecules resulted in a modulation of
dielectric environments around the SWNTs.
HCMV-infected HFLF was grown in Dulbecco’s modified Eagles’
medium (ESI†). After 2 days of incubation, HFLF was collected by
centrifugation and underwent a decomposition procedure to expose
UL44 protein inside HCMV-infected cells to foreign analytes. The
amount of extracted HFLF protein was roughly 150 mg/mL. In vitro
tracing of UL44 was performed using the similar protocol described
above. Six HFLF droplets (2 ml each) were prepared by diluting the
reference sample and loaded onto the nylon membrane. A blank spot
with PBS was also prepared as a control. After skim milk (2 wt%)
blocking, SCMVM34 (2 ml, 0.2 mg/mL) was subsequently added to
the membrane and incubated for 1 h. In the next step, the SWNT-
ssDNA-biotin, avidin and biotin-conjugated antimouse IgG were
reacted with the membrane at a molar ratio of 2 : 1 : 2. The nanotube
concentration in the incubator was 6 mg/L. Finally, the membrane
was thoroughly washed using PBS-T. Fig. 5a shows G modes from
the nylon membrane, and integrated areas are provided in Fig. 5b.
Raw Raman data are provided in the ESI.† The intensity decreased
as the concentration of extracts of HCMV-infected HFLF decreased.Fig. 4 Fluorescence modulation upon interaction between the SWNT-
ssDNA-biotin-avidin-biotin-conjugated antimouse IgG complex and
SCMVM34 in an aqueous solution. Observed shifted energies are as
follows: (6,4) z 0.7 meV, (6,5) z 0.74 meV, (7,5) z 0.15 meV. The inset
shows a blue shift (0.7 meV) for the (6,4) tube after normalizing the
maximum intensity.
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Fig. 5 Targeting of an antigen (UL44 in HCMV-infected HFLF) using
the nanotube probe complex (SWNT-ssDNA-biotin-avidin-biotin-
conjugated antimouse IgG); SCMVM34 was used as a primary antibody:
(a) Raman G mode profiles on the NC membrane; (b) integrated area
intensity under the G mode (from 1585 to 1615 cm1); (c) color reaction































































View OnlineThe Raman signal was negligible when the reference sample was
diluted 108 times whereas the signal from the color test disappeared
when the sample was diluted 104 times (Fig. 5c). Fig. 5 clearly shows
the improved sensitivity, which is on the order of 150 pg/mL,
compared with the colorimetric method. More rigorous comparison
with the ELISA method or other optical labels, such as plasmonic
(Au nanoparticles) labels and quantum dot labels, needs to be carried
out in the future. The cytotoxicity of SWNTs is controversial
depending on experimental conditions.18,19 The dot blotting method is
designed to probe the target antigen in cell extracts. Therefore, the
cytotoxic effect is minimal.
In conclusion, we have demonstrated a new immunoassay using
biotinylated SWNTs as Raman biomarkers. Biotin-conjugated
antimouse IgG was linked to nanotubes through the biotin-avidin
interaction. The nanotube probe could detect a primary antibody
(SCMVM34) and an antigen (UL44) in HCMV-infected HFLF with
excellent sensitivity and specificity. The biotinylated nanotube plat-
form can be readily expanded to a variety of biomolecular probes via
the strong, versatile biotin-avidin reaction.
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